tirzepatide sales Lilly's and Novo Nordisk's semaglutide vie for top drug spot Mounjaro Weight Loss Sales Help

DISCLAIMER Products listed are research compounds intended for in vitro laboratory and research use only

Diabetes Care, 46 (12), 22922299

Brands like Wegovy, approved exclusively for weight management, and Ozempic, approved for type 2 diabetes, are widely recognized

Strive Specialties faces active GLP-1 litigation with two pharmaceutical manufacturers and a pending Ohio board notice from January 2026

Contact us Our science team is here to help, please contact us if you have any questions.

Why NAION Is Being Investigated in GLP-1 Lawsuits Medical researchers and attorneys are examining whether GLP-1 receptor agonist drugs including Ozempic, Wegovy, Rybelsus, Trulicity, Mounjaro, and Zepbound may increase the risk of NAION in certain patients